1. Drugs in development for herpes simplex and varicella zoster virus. Issue 1 (17th March 2017) Authors: Birkmann, A; Zimmermann, H Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 1(2017) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O3-S5.01 Impact of AIC316, a novel antiviral helicase-primase inhibitor, on genital HSV shedding: randomised, double-blind, placebo-controlled trial. (10th July 2011) Authors: Wald, A; Stoelben, S; Tyring, S; Warren, T; Johnston, C; Huang, M L; Timmler, B; Ruebsamen-Schaeff, H; Corey, L; Birkmann, A Journal: Sexually transmitted infections Issue: Volume 87(2011)Supplement 1 Page Start: A78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P3.446 Excellent Efficacy of PRITELIVIR (AIC316) in Suppression of Genital Herpes, a Novel Drug Against Herpes Simplex Virus (HSV) Type 1 and 2. (13th July 2013) Authors: Birkmann, A; McCormick, D; Kropeit, D; Timmler, B; Stoelben, S; Wald, A; Field, H; Richard, M P; Zimmermann, H; Rübsamen-Schaeff, H Journal: Sexually transmitted infections Issue: Volume 89(2013)Supplement 1 Page Start: A288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗